The chairman of the National Committee on COVID vaccination, Valeriu Gheorghita, said on Tuesday that the authorities will most likely propose to stop the vaccination with the serum from AstraZeneca starting next year, given the small number of individuals who have been immunized with this type of vaccine, and the serums from Pfizer, Moderna and Johnson&Johnson will continue to be administered, agerpres reports.
He said it was about "a few tens of people" who were scheduled on the vaccination platform.